News & Updates
Showing Oncology articles
Showing
Show Multimedia Only

MAURIS interim safety and efficacy results in “real-world” ES-SCLC patients similar to IMpower133
28 May 2024
byNatalia Reoutova
Interim results of the Italian, multicentre, open-label, phase IIIb MAURIS trial in “real-world” patients with untreated extensive-stage small-cell lung cancer (ES-SCLC) show similar safety and efficacy to those achieved by atezolizumab plus carboplatin and etoposide in the pivotal, phase I/III IMpower133 trial.
28 May 2024

Many female lung cancer patients left out by screening criteria: study
16 May 2024
byStephen Padilla
The National Lung Screening Trial (NLST) in Singapore falls short of identifying some individuals, particularly women, who are at an increased risk of developing lung cancer, according to a study. However, those who meet the criteria may derive significant benefits from the screening.
16 May 2024






